Latest Lodging News

Tambourah Metals is seeking up to $2.203 million through a non-renounceable one-for-four entitlement offer to fund exploration across its Western Australian portfolio. The offer is not underwritten, and the prospectus warns that further equity may be needed to support the company beyond the short term.

Central Asia Metals has secured the Kazakhstan regulatory approval required for its proposed acquisition of Cygnus Metals, removing a key condition before tomorrow’s Second Court Hearing. The scheme remains subject to the court process and any remaining conditions, with implementation still targeted for 27 October.

Zenith Minerals has reaffirmed its support for Forrestania Resources’ takeover, arguing that the completed Edna May acquisition and A$310 million capital raising outweigh a sharply lower implied offer value. The recommendation comes with a clear split: long-term shareholders may favour the combination, while shorter-term holders may reasonably reject it.

InteliCare Holdings Limited (ASX:ICR) used FY2026 to move from pilot projects into contracted deployment, led by an estimated $8.8 million five-year agreement with mecwacare. Revenue and customer receipts more than doubled, although the company remains loss-making and reliant on disciplined rollout execution and further funding.

Port of Tauranga is facing three appeals and two judicial review applications against approval for its Stella Passage expansion. The port plans to defend the consent and seek a single expedited High Court hearing, but the filing does not quantify possible delays or costs.

Nyrada has received supportive written feedback from the US FDA on its proposed pathway for taking Xolatryp into a US Phase IIa heart-attack trial. The regulator identified no major issues, but additional information and stability data are still required before the planned IND submission in the first half of 2027.

Cynata Therapeutics has lodged a replacement prospectus for a fully underwritten $913,000 entitlement offer, with the cash earmarked largely for adviser costs, intellectual property maintenance and working capital. The raising gives the biotech a near-term funding bridge, but the prospectus again flags a material uncertainty over its ability to continue as a going concern.

Nyrada has lodged a prospectus for approximately 10.74 million free options linked to its recent capital raising, giving eligible CDI holders three options for every four CDIs issued. The options carry a $0.93 exercise price and could generate almost $10 million if fully exercised, although that cash remains contingent on holder participation.

Peet has lodged its draft scheme booklet, including the independent expert’s report, with ASIC as the proposed Ingenia takeover advances towards a shareholder vote. The transaction is targeted for implementation in late December, subject to regulatory, court and shareholder approvals.

AXP Energy has launched a 1-for-1 non-renounceable entitlement offer seeking between A$1.2 million and A$2.249 million. The funding could support Oklahoma development, but the prospectus also highlights material going-concern uncertainty, creditor dependence and significant dilution for shareholders who do not participate.

Surefire Resources has lodged a prospectus for up to 266.6 million new options, although only $90,593 will be raised upfront. The proposed issue would more than quintuple the company’s options on issue and leaves shareholders facing a key approval vote in November.

CVC Limited (ASX:CVC) ended FY26 with $87.7 million in cash after a major Laverton sale, debt refinancing and a decision to abandon a $124 million property settlement. The stronger liquidity position came alongside a 541.7% rise in underlying NPAT, although earnings remain dependent on lumpy property realisations and planning approvals.